Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biostage Inc (NASDAQ:BSTG)

0.766
Delayed Data
As of Jan 20
 -0.0445 / -5.49%
Today’s Change
0.73
Today|||52-Week Range
2.86
-13.93%
Year-to-Date
No recent news for Biostage Inc.

Today’s Trading

Previous close0.81
Today’s open0.80
Day’s range0.74 - 0.80
Volume176,181
Average volume (3 months)115,541
Market cap$13.9M
Dividend yield--
Data as of 3:59pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+25.53%
Earnings growth (this year)+27.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+26.88%
P/E ratioNM
Price/Sales206.07
Price/Book1.38

Competitors

 Today’s
change
Today’s
% change
ETRMEnteroMedics Inc+1.80+29.22%
AMDAAmedica Corp0.000.00%
ALQAAlliqua BioMedical I...+0.00+0.03%
MYOSMYOS RENS Technology...-0.16-4.94%
Data as of 3:59pm ET, 01/20/2017

Financials

Next reporting dateMarch 23, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$118.0K
Annual profit (last year)-$11.7M
Net profit margin-9,918.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
James J. McGorry
Director-Quality &
Operations
Ginger A. Abraham-Freel
Corporate headquarters
Holliston, Massachusetts

Forecasts


Search for Jobs